2025 Subject Index
PDF
Cite
Share
Request
Index
VOLUME: 58 ISSUE: 3
P: 258 - 258
December 2025

2025 Subject Index

Acta Haematol Oncol Turc 2025;58(3):258-258
No information available.
No information available
PDF
Cite
Share
Request
Acquired hemophilia
Acute myeloid leukemia
Acute promyelocytic leukemia
adjuvant
1
adjuvant chemotherapy
adjuvant T-DM1
aged
all-trans retinoic acid
Alpha thalassemia
alpha-globin gene
antibodies
Antibody-drug conjugates
anxiety
arsenic trioxide
Artificial intelligence
Artificial intelligence in oncology
B-cell maturation antigen
Biliary tract cancer
bispecific
Bladder cancer
Breast cancer
breast conserving surgery
CA-19-9 antigen
cancer education
21 ,
Cancer treatment
capecitabine
chatbots
ChatGPT
checkpoint inhibitors
chemotherapy
cholangiocarcinoma
clinical oncology
Colorectal cancer
40 ,
complication
Cyclin-dependent kinase 4/6 inhibitors
cytokine release syndrome
ECOG performance status
effect
epidemiology
8
Epithelial ovarian cancer
Fat pad
FIGO stage
gastrointestinal cancer
gemcitabine-cisplatin combination
gene deletion
genotype-phenotype correlation
geriatric population
germ cell neoplasms
8
HALP score
HER2-positive breast cancer
Hodgkin lymphoma
hormone therapy
Immune thrombocytopenia
immunotherapy
1 ,
61 ,
inappropriate antidiuretic hormone syndrome
inflammatory marker
intraoperative radiotherapy
lung cancer
Lung cancers
1
Lymphoma
mean platelet volume
MELD score
metastasectomy
metastasis
Multiple myeloma
myosteatosis
neoadjuvant
1
neoadjuvant chemotherapy
non-seminomatous germ cell tumor
8
nutritional marker
oncology
oncology clinicians
orbit
Ovarian Cancer-Specific Comorbidity Index (OCCI)
pancreaticoduodenectomy
pathological complete response
pedicled flap
perioperative
1
physiological parameters
postoperative period
prognosis
16 ,
progression free survival
psoas muscle
quality of life
reconstruction
sarcopenia
sebaceous gland neoplasms
second-line chemotherapy
seminoma
8
sexual health
splenectomy
squamous cell carcinoma
stomach neoplasms
super-acute tumor lysis syndrome
survival outcomes
taxanes
Testicular cancer
8
trastuzumab extensive
treatment outcome
treatment planning
Urothelial carcinoma
vinflunine
Virtual reality glasses
WT-1 mutations